Trial Profile
An open, multicentre, randomised parallel group clinical study to compare safety and efficacy of tacrolimus (FK506) with monoclonal anti-IL2R antibodies (daclizumab) vs tacrolimus (FK506) with steroids and evaluate pharmacokinetics in liver allograft recipients receiving suboptimal livers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids; Daclizumab
- Indications Liver transplant rejection
- Focus Registrational; Therapeutic Use
- Acronyms PANTERA
- Sponsors Astellas Pharma
- 07 May 2008 New trial record.